Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
12/2003
12/11/2003CA2482838A1 Pyrazole compounds and pharmaceutical compositions containing the compound
12/10/2003EP1369414A1 Enantiomerically pure Arylcycloalkyl hydroxycarboxylic esters, processes for their preparation and their use as modulators of muscarinic receptors
12/10/2003EP1369410A1 Process for the stereoselective reduction of derivatives of 4-aryl-4-oxobutyric acid
12/10/2003EP1368346A1 Substituted benzofuran-2-carboxamides derivatives
12/10/2003EP1368344A1 Piperazine derivatives, their preparation and uses in therapy (5ht1b receptor activity)
12/10/2003EP1368342A2 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
12/10/2003EP1368340A1 Piperazine derivatives as melanocortin receptor agonists
12/10/2003EP1368336A2 Thiophene substituted amine derivatives as glyt-1 inhibitors
12/10/2003EP1368325A1 New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates
12/10/2003EP1368324A1 Quinazolines as mmp-13 inhibitors
12/10/2003EP1368323A1 Pyrimidine matrix metalloproteinase inhibitors
12/10/2003EP1368320A1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof
12/10/2003EP1368318A2 Calcilytic compounds
12/10/2003EP1368032A1 Excitatory amino acid receptor antagonists
12/10/2003EP1367893A1 Pyridyl pyrimidines for use as pesticides
12/10/2003EP1115721B1 Pyrimidone derivatives
12/10/2003EP1091953B1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
12/10/2003EP0970046B1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
12/10/2003EP0714396B1 Vasocontrictive dihydrobenzopyran derivatives
12/10/2003EP0628064B2 Photochromic naphthopyrans
12/10/2003CN1130360C Substituted thienocycloalk (en)ylamino-1,3,5-triazine
12/10/2003CN1130358C Imidzzole compounds and preparing method and application thereof
12/10/2003CN1130351C 1,5-benzodiazepine derivatives
12/09/2003US6660866 C10 carbonate substituted taxanes
12/09/2003US6660760 Heterocyclic aromatic compounds useful as growth hormone secretagogues
12/09/2003US6660752 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
12/09/2003US6660751 Sulfonamide derivatives as 5-HT7 receptor antagonists
12/09/2003US6660740 Sorbitol dehydrogenase inhibitors
12/09/2003US6660739 Heterocyclic amides as inhibitors of factor Xa
12/09/2003US6660738 Such as (3R,5S)-1-pyrimidin-2-yl-5-(2,4,5-trifluoro-benzyloxymethyl)-pyrrolidine-3 -thiol trifluoro-acetate useful as inhibitors of metalloproteases for treating diseases associated with vasoconstriction
12/09/2003US6660736 MAO-B inhibitors
12/09/2003US6660732 Ureas and thioureas inhibit production of cytokines
12/09/2003US6660731 Pyrazole compounds useful as protein kinase inhibitors
12/09/2003US6660728 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
12/09/2003CA2189593C Sulphonylaminocarbonyltriazolinones having substituents bonded via oxygen
12/04/2003WO2003099812A1 Phenyl-furan or phenyl-thiophene derivatives, their preparation and their use as medicine
12/04/2003WO2003099805A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
12/04/2003WO2003099795A1 4-substituted imidazole-2-thiones and imidazol-2-ones as agonists of the alpha-2b and alpha-2c adrenergic receptors
12/04/2003WO2003099787A1 Novel piperidine compound
12/04/2003WO2003099786A2 Aromatic sulfones and their medical use
12/04/2003WO2003099773A1 Ccr9 inhibitors and methods of use thereof
12/04/2003WO2003099765A1 β-ALANINE DERIVATIVE AND USE THEREOF
12/04/2003WO2003099284A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/04/2003WO2003099276A1 1,1-disubstituted cycloalkyl derivatives as factor xa inhibitors
12/04/2003WO2003099266A2 Acetamides and benzamides that are useful in treating sexual dysfunction
12/04/2003WO2003063794A3 2,4-pyrimidinediamine compounds and their uses
12/04/2003WO2003027085A3 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors
12/04/2003WO2002094796A3 Benzo[g]quinoxaline derivatives as effective compounds against infectious diseases
12/04/2003WO2002068397A8 Diaminoquinazoline esters for use as dihydrofolate reductade inhibitors
12/04/2003US20030225288 Small organic compounds to modulate chemokine receptor activity; treating psoriasis, autoimmune diseases, multiple sclerosis, graft rejection, infectious diseases; anti-allergen, -arthritic, -inflammatory, carcinogenic agents
12/04/2003US20030225283 2-Substituted phenyl,3-polar ring,N-heroaromatic propion-amides, e.g., 1-(2-(3,4-Dichlorophenyl)-3-(tetrahydro-furan-2-yl)-propionyl)-3- methylurea; antidiabetic agents; increase the flux of glucose metabolism in beta-cells and hepatocytes
12/04/2003US20030225281 Piperidines derivatives and their use as serotonin receptor antagonists
12/04/2003US20030225276 Prostaglandin endoperoxide H synthase biosynthesis inhibitors
12/04/2003US20030225269 Inhibitors of interleukin-1beta converting enzyme
12/04/2003US20030225228 A catalyst for the polymerization of olefins, contains a titanium zirconium or hafnium complex of a dianionic bidentate ligand, (at least one of donor atoms of the ligand is a nitrogen atom substituted by a pyrrolyl group)
12/04/2003US20030225150 Method of using a COX-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasia
12/04/2003US20030225148 Biological methods of use of 4-amino-3-mercapto-triazoles
12/04/2003US20030225121 Treatment of a disorder of the central nervous system related to or affected by the 5-HT6 receptor
12/04/2003US20030225115 Anticoagulants
12/04/2003US20030225109 Inducing contraception, treat progesterone-related carcinomas and adenocarcinomas; hormone replacement therapy
12/04/2003US20030225106 Prophylaxis and treatment of angiogenesis mediated diseases such as cancer
12/04/2003US20030225100 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method of preparing same and compositions containing same
12/04/2003US20030225097 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by np y5 receptor
12/04/2003US20030225085 For reducing neuronal cell death in response to a traumatic event
12/04/2003US20030225084 Have an affinity for the gabapentin binding site and can be used to treat conditions such as pain, epilepsy, migraine and others.
12/04/2003US20030225077 Naphthylamines used to chronic inflammatory diseases.
12/04/2003US20030225071 N-heterocyclic amides and carbamates
12/04/2003US20030225061 Protease inhibitors
12/04/2003US20030225057 3-Benzoazepine derivatives
12/04/2003US20030225053 N-arylcarboxamides of fused ring systems including naphthalenes, benzothiophenes, benzofurans and indoles
12/04/2003US20030225043 Especially for inhibiting type IV collagenase
12/04/2003US20030224442 Comprises nucleotide sequences coding g-protein coupled receptor for use in treatment of anxiety, depression, obsessive-compulsive, schizophrenia autism, migraine, emesis, alcoholism and neurodegenerative disorders
12/04/2003US20030224288 Stimulation sensitive composition and compound
12/04/2003CA2784937A1 Ccr9 inhibitors and methods of use thereof
12/04/2003CA2486962A1 Compounds
12/04/2003CA2486564A1 Acetamides and benzamides that are useful in treating sexual dysfunction
12/04/2003CA2486376A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/04/2003CA2484822A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
12/03/2003EP1367055A1 Isoquinolinyl carboxamides and their use as anticonvulsants
12/03/2003EP1366043A1 2-heteroaryl-3,4-dihydro-2h-pyrrole derivatives and the use thereof as pesticides
12/03/2003EP1366038A1 Cdk-1 inhibitor oxindoles and the application thereof in therapeutics
12/03/2003EP1366028A1 Diaminoquinazoline esters for use as dihydrofolate reductase inhibitors
12/03/2003EP1119557B1 Indeno-, naphto- and benzocyclohepta dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
12/03/2003EP1117659B1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
12/03/2003EP0937070B1 Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
12/03/2003EP0786455B1 Imidazole derivative
12/03/2003CN1129605C Modified aminoacids, pharmaceuticals containing these compounds and mehtod for their prodn
12/03/2003CN1129596C Synthetic intermediate of cephalo olefine compound
12/03/2003CN1129591C O-substituted hydroxycumaranone derivatives as antitumor and antimetastatic agents
12/03/2003CN1129584C Pyrimidinyloxyalkanoic amide derivatives and fungicides for agricultural and horiticultural use
12/03/2003CN1129583C Compound as intermediates for use in preparation of optically active 2-imidazoline-5-one or 2-imidazoline-5-thionone derivatives
12/03/2003CN1129578C Tetrahydrobenzindole derivs
12/03/2003CN1129576C Phenyl heterocyclic compound used as epoxy enzyme-2 inhibitor
12/02/2003US6657070 Production of chirally pure α-amino acids and N-sulfonyl α-amino acids
12/02/2003US6657060 Neuropeptide Y antagonists; treatment of eating disorders such as obesity and hyperphagia
12/02/2003US6656966 Nitrosated and nitrosylated taxanes, compositions and methods of use
12/02/2003US6656957 Pyridine derivatives
12/02/2003US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
12/02/2003US6656939 Pyrazole compounds useful as protein kinase inhibitors
12/02/2003US6656933 Novel compounds which inhibit production of cytokines involved in inflammatory processes